The Consumer Network for Public Interest urged the National Assembly Legislation and Judiciary Committee to immediately process the pending Tobacco Business Act amendment bill.The network stated in a release on Tuesday that the Tobacco Business Act amendment has been repeatedly obstructed during rev
Korea United Pharm held a seminar for medical professionals to launch its aspirin–clopidogrel combination, Clavixin Duo Capsule, in the Mongolian market.Last Thursday, Korea United Pharm invited over 50 Mongolian cardiologists to the Ramada Hotel in Ulaanbaatar for a launch seminar on Clavixin Duo C
Severance Cardiovascular Hospital said Wednesday it has become the first medical institution in Korea to complete 100 cases of the Varipulse pulsed field ablation (PFA) procedure, reaching the milestone on Nov. 20.The achievement comes less than a year after Severance introduced PFA in Korea last De
Roche Korea outlined its expanding lymphoma portfolio during a media session at its headquarters in Seoul on Tuesday, presenting evidence for Polivy (polatuzumab vedotin) and Columvi (glofitamab) as global guidelines increasingly position both therapies at the center of diffuse large B cell lymphoma
Neurophet, a Korean company that develops AI tools for brain disease diagnosis, said on Tuesday that it had entered a joint research collaboration with the Florey Institute of Neuroscience and Mental Health in Australia to refine dementia diagnostics in routine clinical care.The project will use Neu
Oscotec announced progress across its clinical pipeline, highlighting ADEL-Y01 and candidate compounds OCT-598 and P4899 aimed at overcoming next-generation anticancer treatment resistance.The company did so at the “2025 Second Half R&D Day” held on Monday at the Federation of Korean Industries buil
The KOSMOS-II project by the Korean Society of Medical Oncology (KSMO) received national recognition for advancing precision medicine and patient care, earning the Minister of Health and Welfare Award.KOSMOS-II is a study that uses next-generation sequencing (NGS) to develop individualized treatment
Samsung is deepening its bet on antibody-drug conjugates (ADCs) with a new equity investment in China-based Phrontline Biopharma, adding capital to an October licensing deal that brought Phrontline’s dual-payload ADC platform into Samsung Bioepis’ oncology pipeline.Samsung Life Science Fund, an inve
Celltrion is accelerating its European market expansion for Omlyclo, a biosimilar referencing Novartis’ Xolair, after completing launches in major markets including Germany, Spain, the U.K., and France.Omlyclo is an antibody biopharmaceutical with the same composition as the original drug, Novartis'
Researchers have released results from a long-term study of Galafold (migalastat) in Korean patients with Fabry disease and a compliant mutation.Professor Cheon Chong-kun of the Department of Medical Genetics at Pusan National University Children's Hospital presented these findings at the 70th fall
Korea University Medicine (KU Medicine) will build its fourth hospital, a 700-bed facility, in Dongtan 2 New Town in Hwaseong, Gyeonggi Province.KU Medicine announced on Monday that Hwaseong City and the Korea Land and Housing Corp. (LH) evaluated its master plan, medical capabilities, community con
Merck Healthcare Korea has designated 2025 as the starting point for its oncology business, saying it has completed a fully reimbursed cancer treatment portfolio in the Korean market and is now positioned to accelerate both patient access and pipeline expansion.The company emphasized what it calls t
TiUM Bio announced on Tuesday that it has received approval from the World Health Organization (WHO) for the International Nonproprietary Name (INN) of its anticancer drug candidate TU2218 as “tosposertib.”TiUM Bio explained that tosposertib is a combination of “tospo,” meaning “together,” and the s
While 'K-Healthcare' could drive growth, experts highlight that policy is not aligned with industry needs, calling for regulatory easing, such as telemedicine and visa improvements, to boost medical tourism.Reflecting these sentiments, a public hearing titled “The Future and Revitalization Strategie
Korean drugmakers are commissioning facilities designed to pass U.S. and European inspections on the first attempt, and they want those requirements fixed in the blueprint before concrete is poured.AtkinsRéalis, the Montreal-based design and project firm that entered Korea in 2007 and opened a Seoul
The fact that men and women respond differently to the same drugs due to biological and social differences is gaining renewed attention.Against this backdrop, the Women's Heart Disease Research Working Group under the Korean Society of Cardiology has launched a “Gender Difference Medicine Awareness
SK plasma said it had signed a shareholders’ agreement with the Turkish Red Crescent (Kizilay) in Ankara, Türkiye, on Tuesday (local time). The agreement covers the construction of a PDMP plasma plasma-derived medicinal products) plant and the establishment of a joint venture named Proturk, aimed at
Treatment access for spinal muscular atrophy (SMA) in Korea remains constrained by structural barriers even as disease-modifying therapies become more widely available.SMA is a genetic neuromuscular disease in which a lack of survival motor neuron protein leads to progressive muscle weakness, respir
Forty percent of Koreans consider all medical services covered by national health insurance to be essential medical care.A large share of people also cited "emergency, trauma, and cardiovascular care" as essential medical services that the government should provide with a sense of state responsibili
GC Biopharma announced on Monday that it received an “A” rating in the 2025 KCGS ESG Evaluation by the Korea Institute of Corporate Governance and Sustainability (KCGS), representing an upgrade from its previous rating.KCGS comprehensively evaluates the sustainable management levels of listed Korean
